Home / Drug shortages / Podophyllum Resin Topical Tincture

Podophyllum Resin Topical Tincture — FDA Drug Shortage

To Be Discontinued — Padagis US LLC

The FDA lists a drug shortage record for Podophyllum Resin Topical Tincture from Padagis US LLC with status To Be Discontinued. The shortage was first posted on 07/23/2026.

Shortage Details

Status
To Be Discontinued
Company
Padagis US LLC
Package NDC
0574-0601-15
Dosage Form
Presentation
Podocon 25, Topical Tincture, 1 mg/4 mL (NDC 0574-0601-15)
Initial Posting
07/23/2026
Revised Date

FDA data resources